The price of LifeStance Health Group Inc. (NASDAQ:LFST) shares last traded on Wall Street rose 3.39% to $5.79.
Based on available information, 6 analysts follow LifeStance Health Group Inc. (NASDAQ:LFST). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $8.00 and a low of $7.00, we find $7.55. Given the previous closing price of $5.60, this indicates a potential upside of 34.82 percent. LFST stock price is now 13.85% away from the 50-day moving average and -7.65% away from the 200-day moving average. The market capitalization of the company currently stands at $2.06B.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
Among analysts, 2 rate the stock a hold while 4 rate it a buy. Brokers who have rated the stock have averaged $7.51 as their price target over the next twelve months.
With the price target maintained at $8, Morgan Stanley recently Upgraded its rating from Equal-Weight to Overweight for LifeStance Health Group Inc. (NASDAQ: LFST)., while ‘UBS’ rates the stock as ‘Neutral’.
In other news, Gouk Warren, Chief Administrative Officer sold 15,106 shares of the company’s stock on Nov 07. The stock was sold for $108,763 at an average price of $7.20. Upon completion of the transaction, the Chief Administrative Officer now directly owns 5,967,991 shares in the company, valued at $34.55 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 31, Chief Administrative Officer Gouk Warren sold 15,106 shares of the business’s stock. A total of $113,144 was realized by selling the stock at an average price of $7.49. This leaves the insider owning 5,983,097 shares of the company worth $34.64 million. Insiders disposed of 1,186,322 shares of company stock worth roughly $6.87 million over the past 1 year. A total of 3.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in LFST stock. A new stake in LifeStance Health Group Inc. shares was purchased by MILLENNIUM MANAGEMENT LLC during the first quarter worth $1,801,000. PROSIGHT MANAGEMENT, LP invested $1,675,000 in shares of LFST during the first quarter. In the first quarter, TUDOR INVESTMENT CORP ET AL acquired a new stake in LifeStance Health Group Inc. valued at approximately $486,000. PARAMETRIC PORTFOLIO ASSOCIATES LLC acquired a new stake in LFST for approximately $367,000. RENAISSANCE TECHNOLOGIES LLC purchased a new stake in LFST valued at around $178,000 in the second quarter. In total, there are 132 active investors with 82.30% ownership of the company’s stock.
A candlestick chart of LifeStance Health Group Inc. (NASDAQ: LFST) showed a price of $5.59 on Thursday morning. During the past 12 months, LifeStance Health Group Inc. has had a low of $4.22 and a high of $11.25. As of last week, the company has a debt-to-equity ratio of 0.14, a current ratio of 2.20, and a quick ratio of 2.20. The fifty day moving average price for LFST is $5.09 and a two-hundred day moving average price translates $6.27 for the stock.
The latest earnings results from LifeStance Health Group Inc. (NASDAQ: LFST) was released for Sep, 2022. According to the Medical Care Facilities Company, earnings per share came in at -$0.11, beating analysts’ expectations of -$0.14 by 0.03. This compares to -$0.35 EPS in the same period last year. The net profit margin was -33.80% and return on equity was -18.00% for LFST. The company reported revenue of $217.56 million for the quarter, compared to $173.84 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 25.15 percent. For the current quarter, analysts expect LFST to generate $217.11M in revenue.
LifeStance Health Group Inc.(LFST) Company Profile
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
